Effects of aluminum and zinc on the oxidative stress caused by 6-hydroxydopamine autoxidation:: relevance for the pathogenesis of Parkinson's disease

被引:50
作者
Méndez-Alvarez, E
Soto-Otero, R
Hermida-Ameijeiras, A
López-Real, AM
Labandeira-García, JL
机构
[1] Univ Santiago de Compostela, Fac Med, Dept Bioquim & Biol Mol, Grp Neuroquim, E-15782 Santiago De Compostela, Spain
[2] Univ Santiago de Compostela, Fac Med, Dept Ciencias Morfol, Lab Neuroanat & Neurol Expt, E-15782 Santiago De Compostela, Spain
来源
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE | 2002年 / 1586卷 / 02期
关键词
6-hydroxydopamine; aluminum; zinc; antioxidant; oxidative stress; Parkinson's disease;
D O I
10.1016/S0925-4439(01)00077-1
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Aluminum and zinc have been related to the pathogenesis of Parkinson's disease (PD), the former for its neurotoxicity and the latter for its apparent antioxidant properties. 6-Hydroxydopamine (6-OHDA) is an important neurotoxin putatively involved in the pathogenesis of PD, its neurotoxicity often being related to oxidative stress. The potential effect of these metals on the oxidative stress induced by 6-OHDA autoxidation and the potential of ascorbic acid (AA), cysteine, and glutathione to modify this effect were investigated. Both metals, particularly Al3+, induced a significant reduction in (OH)-O-. production by 6-OHDA autoxidation. The combined action of AA and a metal caused a significant and sustained increase in (OH)-O-. generation, particularly with Al3+, while the effect of sulfhydryl reductants was limited to only the first few minutes of the reaction. However, both Al3+ and Zn2+ provoked a decrease in the lipid peroxidation induced by 6-OHDA autoxidation using mitochondrial preparations from rat brain, assessed by TBARS formation. In the presence of AA, only Al3+ induced a significant reduction in lipid peroxidation. After intrastriatal injections of 6-OHDA in rats, tyrosine hydroxylase immunohistochemistry revealed that Al3+ reduces 6-OHDA-induced dopaminergic lesion in the striatum, which corroborates the involvement of lipid peroxidation in 6-OHDA neurotoxicity and appears to discard the participation of this mechanism on PD by Al3+ accumulation. The previously reported antioxidant properties of Zn2+ appear to be related to the induction of Zn2+-containing proteins and not to the metal per se. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:155 / 168
页数:14
相关论文
共 50 条
  • [21] Molecular Profiling of a 6-Hydroxydopamine Model of Parkinson’s Disease
    Sang J. Na
    Anthony G. DiLella
    Edward V. Lis
    Keith Jones
    David M. Levine
    David J. Stone
    J. F. Hess
    [J]. Neurochemical Research, 2010, 35 : 761 - 772
  • [22] Neuroprotective and Antiapoptotic Potential of Trigonelline in a Striatal 6-Hydroxydopamine Rat Model of Parkinson’s Disease
    M. Mirzaie
    M. Khalili
    Z. Kiasalari
    M. Roghani
    [J]. Neurophysiology, 2016, 48 : 176 - 183
  • [23] Synchrotron FTIR Microspectroscopy Study of the Striatum in 6-Hydroxydopamine Rat Model of Parkinson's Disease
    Zhu Hongyan
    Xiao, Pei
    Wu Lingyan
    Bo, Liu
    Qi Zeming
    Wang Yuyin
    [J]. SPECTROSCOPY-AN INTERNATIONAL JOURNAL, 2012, 27 (04): : 229 - 238
  • [24] Neuroprotective and Antiapoptotic Potential of Trigonelline in a Striatal 6-Hydroxydopamine Rat Model of Parkinson's Disease
    Mirzaie, M.
    Khalili, M.
    Kiasalari, Z.
    Roghani, M.
    [J]. NEUROPHYSIOLOGY, 2016, 48 (03) : 176 - 183
  • [25] Metabolic–dopaminergic mapping of the 6-hydroxydopamine rat model for Parkinson’s disease
    Cindy Casteels
    Erwin Lauwers
    Guy Bormans
    Veerle Baekelandt
    Koen Van Laere
    [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2008, 35 : 124 - 134
  • [26] Parkinson's Disease and the Heart: Studying Cardiac Metabolism in the 6-Hydroxydopamine Model
    da Fonseca, Victor Silva
    Goncalves, Valeria de Cassia
    Izidoro, Mario Augusto
    de Almeida, Antonio-Carlos Guimaraes
    Fonseca, Fernando Luiz Affonso
    Scorza, Fulvio Alexandre
    Finsterer, Josef
    Scorza, Carla Alessandra
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (15)
  • [27] Afobazole Restores the Dopamine Level in a 6-Hydroxydopamine Model of Parkinson's Disease
    Voronin, M. V.
    Kadnikov, I. A.
    Seredenin, S. B.
    [J]. NEUROCHEMICAL JOURNAL, 2019, 13 (01) : 49 - 56
  • [28] The beneficial effect of vanillin on 6-hydroxydopamine rat model of Parkinson's disease
    Abuthawabeh, Rasha
    Abuirmeileh, Amjad N.
    Alzoubi, Karem H.
    [J]. RESTORATIVE NEUROLOGY AND NEUROSCIENCE, 2020, 38 (05) : 369 - 373
  • [29] Effects of puerarin on gait disturbance in a 6-hydroxydopamine mouse model of Parkinson's disease
    Kim, Na-Hyun
    Goto, Yukiori
    Lee, Young-A
    [J]. PHARMACOLOGICAL REPORTS, 2025, 77 (01) : 247 - 259
  • [30] Copper increases the ability of 6-hydroxydopamine to generate oxidative stress and the ability of ascorbate and glutathione to potentiate this effect: potential implications in Parkinson's disease
    Cruces-Sande, Anton
    Mendez-Alvarez, Estefania
    Soto-Otero, Ramon
    [J]. JOURNAL OF NEUROCHEMISTRY, 2017, 141 (05) : 738 - 749